GRCE: Grace Therapeutics Inc PEG multiplikatori
Grace Therapeutics, Inc. (GRCE) etik madaniyat va aksiyalar opsionlari orqali yetakchi bioximiklarni jalb qilmoqda, shu bilan birga moslashuvchanlikni saqlash uchun ishlab chiqarishni uchinchi tomon pudratchilariga autsorsing qilmoqda. P/E o'sish potentsiali koeffitsiyenti ushbu strategiyaning natijasini aks ettiradi va ushbu ko'rsatkich 0.00 darajasida turibdi. Kam uchraydigan asab tizimi patologiyalari uchun ilg'or inyeksiyalarga bo'lgan yuqori talab kompaniyaga o'z mijozlar bazasini sezilarli darajada kengaytirish imkoniyatini va'da qilmoqda.
Grace Therapeutics, Inc. (GRCE) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- balans bo'yicha xususiy kapital ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Barcha qarzlarning o‘z mablag‘lariga nisbati Grace Therapeutics, Inc.|GRCE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli kreditlarning kapitalga nisbati gracetx.com|GRCE - Kompaniyaning jamlangan qarzlari|Qarzning sof aktivlarga nisbati Grace Tx|GRCE - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Grace Therapeutics|Oraliq qoplash koeffitsiyenti gracetx.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
GRCE - Sof foyda|Prognoz qilingan kelajakdagi foyda Grace Therapeutics, Inc.|GRCE - Narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati gracetx.com|GRCE - PEG multiplikatori|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Grace Tx|GRCE - Eskirish chegirilmasdan oldingi operatsion foyda|Bir aksiya uchun sof foyda (EPS TTM) Grace Therapeutics|GRCE - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sish sur'ati gracetx.com|GRCE - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Grace Therapeutics, Inc.
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning umumiy tahlili:Grace Therapeutics Inc, GRCE
Grace Therapeutics, Inc. (GRCE) nevrologik patologiya dori vositalari uchun klinik sinovlarga e'tibor qaratadi va hozirda tijorat daromadlariga ega emas. Bunday sharoitda, moslashtirilgan PEG koeffitsiyenti bozor bahosini foyda o'sishi dinamikasi bilan solishtiradi. Ushbu ko'rsatkich koeffitsientning biznes kengayishi sur'atiga nisbatan adolatli ekanligini aniqlaydi. Birga solishtirganda pastroq qiymat aktivning qadr-qimmati past baholanganligidan dalolat beradi. Ushbu egri chiziqni tahlil qilish kompaniyaning qiymati keskin oshish potentsialini aniqlash imkonini beradi.
Raqobatdosh kompaniyalar
BIIB (Biogen Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori NBIX (Neurocrine Biosciences Inc)|PEG multiplikatori Regencell Corp RGC|Axsome Therapeutics - PEG multiplikatori|acadia-pharm.com (ACAD) - Narx-foyda va o‘sish multiplikatori|XENE: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Viking Therapeutics Inc (VKTX)|Narx-foyda va o‘sish multiplikatori SUPN|CPRX: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori DNLI (Denali Therapeutics)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati HRMY|PEG multiplikatori BHVN (Biohaven)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti AMLX|Trevi Pharma - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Praxis Corp|Anavex Life Sciences (AVXL) - Narxning foydaga va o‘sish sur’atiga nisbati|ceribell.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PRTA (Prothena Corporation plc) - PEG multiplikatori|PEG multiplikatori Alector Therapeutics|Narxning foydaga va o‘sish sur’atiga nisbati Annexon Inc. (ANNX)|OMER: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori NGNE (Neurogene Inc.)|acimmune.com (ACIU) - O‘sish sur’atiga tuzatilgan narx-foyda|VYGR: Narx-foyda va o‘sish multiplikatori|NMRA - PEG multiplikatori|SCLX (Scilex Holding Co.) - Narx-foyda va o‘sish multiplikatori|TVGN: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|ACOG (Alpha Cognition Inc) - PEG multiplikatori|cogrx.com (CGTX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori IKT|Narx-foyda va o‘sish multiplikatori Cassava Sciences Inc SAVA|Narxning foydaga va o‘sish sur’atiga nisbati Assertio ASRT|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Coya Therapeutics Inc (COYA)|VTGN: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti OVID (Ovid Therapeutics Inc.)|ABOS: PEG multiplikatori|CRVO - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Alterity Therapeutics Ltd.|O‘sishni hisobga olgan narx-foyda koeffitsiyenti CLNN (Clene Nanomedicine)|PEG multiplikatori PEPG|Narx-foyda va o‘sish multiplikatori jupiterneurosciences.com JUNS|Relmada Therapeutics, Inc. - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Annovis Bio Inc (ANVS)|Firefly Neuroscience Inc - PEG multiplikatori|Narxning sof foyda o‘sishiga nisbati Klotho Neurosciences Inc (KLTO)|neurosense-tx.com (NRSN) - Narxning foydaga va o‘sish sur’atiga nisbati|revivapharma.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|MTVA (MetaVia Inc.) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori NeurAxis Inc. (NRXS)|PEG multiplikatori HSDT|PASG - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Neuphoria Therapeutics NEUP|NERV: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Athira Pharma - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Addex Therapeutics Ltd.|ALZN (alzamend.com) - Narx-foyda va o‘sish multiplikatori|Cyclerion Therapeutics, Inc. (CYCN) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Protagenic Therapeutics Inc.|KTTA: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Cortigent, Inc. (CRGT)|ATXI - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori BCLI (Brainstorm Cell Therapeutics, Inc.)|Narxning sof foyda o‘sishiga nisbati Cara Therapeutics Inc|CHRO - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ELYM (Eliem Therapeutics)|ITCI: PEG multiplikatori|Longboard Pharmaceuticals Inc (LBPH) - PEG multiplikatori|MRNS (Marinus) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori NKGen Biotech Corp (NKGN)|PEG multiplikatori NRBO|SAGE - O‘sish sur’atiga tuzatilgan narx-foyda|Synaptogenix - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti TRVN|VIGL: Narx-foyda va o‘sish multiplikatori|Anew Medical Inc. - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|CERE: PEG multiplikatori
